Skip to main content

Table 1 Clinical and laboratory data of 22 patients with autoimmune rheumatic disease (AIRD) and positive cytomegalovirus antigenemia

From: Incidence of Cytomegalovirus Antigenemia in patients with autoimmune rheumatic diseases: a 3-year retrospective study

Patient

Age (years)/ Sex

AIRD

Immunosuppressive therapy in hospital

Lymphocyte Count (/μl)

Positive CMV antigenemia nuclei (/200.000PMN)

Sites involved by CMV infection

Symptoms

Outcome

1

67/F

SLE

CFA, PDN 130 mg/day

1311

32

Gut

Esophageal ulcers

Death

2

34/F

SLE

AZA, CFA, PDN 80 mg/day

1356

1

Lung

Cough, dyspnea, fever

Improvement

3

17/F

SLE

PDN 200 mg/day

444

2

Cytopenia

Neutropenia, Thrombocytopenia

Improvement

4

22/F

SLE

PDN 60 mg/day

695

5

Gut

Mouth ulcers

Improvement

5

21/F

SLE

PDN 60 mg/day

135

500

Cytopenia / Lung

Trombocyotpenia, Cough, dyspnea, fever

Death

6

25/F

SLE

PDN 180 mg/day

525

1

Lung

Cough, dyspnea, fever

Death

7

16/F

SLE

MP + CFA, PDN 50 mg/day

850

108

Cytopenia

Febrile neutropenia

Improvement

8

20/F

SLE

MP + CFA, PDN 60 mg/day

792

1

Gut

Esophageal ulcers

Improvement

9

38/F

SLE

PDN 60 mg/day

2751

2

Lung

Cough, dyspnea, fever

Improvement

10

30/F

SLE

CFA, PDN 60 mg/day

659

2

Cytopenia

Pancytopenia, fever

Death

11

25/F

SLE

MMF, MP, PDN 50 mg/day

853

164

Cytopenia

Anemia, Thrombocytopenia

Improvement

12

37/F

SLE

PDN 60 mg/day

80

46

Cytopenia /Gut

Anemia, diarrhea

Improvement

13

26/F

SLE

MP + CFA, PDN 90 mg/day

714

2

Lung

Cough, dyspnea

Improvement

14

77/F

SE

125

1

Cytopenia

Pancytopenia, fever

Death

15

29/M

Overlap Sd.

PDN160mg/day

246

16

Lung

Cough, dyspnea

Death

16

70/M

RA

MP, PDN 20 mg/day

77

1

Cytopenia

Pancytopenia, fever

Improvement

17

17/M

RA

PDN 160 mg/day

689

1

Lung

Cough, dyspnea

Death

18

42/F

MPA

PDN 100 mg/day

197

4

Lung

Cough, dyspnea, Fever

Death

19

77/F

MPA

PDN 100 mg/day

372

500

Cytopenia / Lung

Anemia, Leukopenia, Cough, Fever

Death

20

63/F

GPA

CFA, PDN 30 mg/day

857

9

Gut

Gastric ulcer

Improvement

21

58/M

GPA

AZA, MP, PDN 120 mg/day

213

73

Gut

Gastric ulcer

Death

22

55/F

Anti-sintetase Sd.

CFA, PDN 100 mg/day

975

7

Lung

Cough, dyspnea

Improvement

  1. CMV cytomegalovirus, SLE Systemic Lupus Erythematosus, SE Systemic sclerosis, Overlap syndrome Systemic Lupus Erythematosus + Systemic sclerosis + polymyositis, RA rheumatoid arthritis, MPA microscopic polyangiitis, GPA granulomatosis with polyangiitis, F Female, M, Male, AIRD autoimmune rheumatic disease, PDN Prednisone, AZA Azathioprine, MMF mycophenolate mofetil, CFA Cyclophosphamide (pulse), MP Methylprednisolone (pulse), MP + CFA combined pulse: methylprednisolone and cyclophosphamide. a: Maximum dose during hospitalization. b: methylprednisolone pulse 1 g / day for 3 consecutive days